what's considered a microdose of semaglutide Can You Ozempic and Other GLP-1s? A Comprehensive Guide to Semaglutide

Neither directly affects UTI risk, but both require monitoring that should include kidney function tests, which can incidentally identify early urinary tract issues

It has not received a marketing authorisation from the MHRA, nor has it been recommended by the National Institute for Health and Care Excellence (NICE) for any clinical indication

Current evidence, including magnetic resonance imaging studies, suggests that skeletal muscle alterations resulting from GLP-1 RA-induced weight loss, such as enhanced insulin sensitivity and reduced muscle fat infiltration, are adaptive, thereby improving muscle quality despite concurrent reductions in lean mass [112]

Pietrantoni, A